Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
William R. Carpenter, MHA, PhD
Advertisement
Articles by William R. Carpenter, MHA, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%
4
Small Workflow Changes Close Big Gaps in CKM Screening
5